Overview

Phase 3 Study to Evaluate the Efficacy and Safety of the DW0929 in Patients With Primary Hypercholesterolemia

Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of the DW0929 in patients with primary hypercholesterolemia
Phase:
Phase 3
Details
Lead Sponsor:
Daewon Pharmaceutical Co., Ltd.
Treatments:
Rosuvastatin Calcium